Triple

T22113269
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 141/2000 on orphan medicinal products E546469 entity
Predicate relatedTo P37 FINISHED
Object EU pharmaceutical legislation NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: EU pharmaceutical legislation | Statement: [Regulation (EC) No 141/2000 on orphan medicinal products, relatedTo, EU pharmaceutical legislation]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: EU pharmaceutical legislation
Context triple: [Regulation (EC) No 141/2000 on orphan medicinal products, relatedTo, EU pharmaceutical legislation]
  • A. European Union pharmaceutical legislation chosen
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • B. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • C. EU regulations
    EU regulations are binding legislative acts of the European Union that apply directly and uniformly in all member states, shaping common policies and legal standards across the EU.
  • D. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • E. European Pharmacopoeia
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e38b3848190ac3a4fa97d56e65a completed April 16, 2026, 5:36 p.m.
NER Named-entity recognition batch_69f1294b9d5c8190897b760ca4f3b09a completed April 28, 2026, 9:40 p.m.
Created at: April 16, 2026, 8:31 p.m.